Oppenheimer Asset Management’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.2M | Sell |
14,228
-79,543
| -85% | -$6.42M | 0.01% | 701 |
|
|
2026
Q1 | $6.63M | Sell |
93,771
-2,297
| -2% | -$172K | 0.08% | 280 |
|
|
2025
Q4 | $7.58M | Sell |
96,068
-393
| -0.4% | -$31.1K | 0.09% | 233 |
|
|
2025
Q3 | $7.95M | Sell |
96,461
-4,276
| -4% | -$337K | 0.09% | 254 |
|
|
2025
Q2 | $8.1M | Sell |
100,737
-1,444
| -1% | -$111K | 0.09% | 239 |
|
|
2025
Q1 | $8.2M | Buy |
102,181
+3,719
| +4% | +$309K | 0.1% | 225 |
|
|
2024
Q4 | $8.06M | Buy |
98,462
+1,913
| +2% | +$159K | 0.1% | 226 |
|
|
2024
Q3 | $7.96M | Sell |
96,549
-1,523
| -2% | -$114K | 0.1% | 231 |
|
|
2024
Q2 | $6.88M | Buy |
98,072
+14,233
| +17% | +$1.02M | 0.09% | 252 |
|
|
2024
Q1 | $6.21M | Sell |
83,839
-11,556
| -12% | -$805K | 0.09% | 246 |
|
|
2023
Q4 | $6.31M | Sell |
95,395
-3,925
| -4% | -$246K | 0.09% | 261 |
|
|
2023
Q3 | $6.25M | Buy |
99,320
+1,317
| +1% | +$82K | 0.1% | 244 |
|
|
2023
Q2 | $5.54M | Buy |
98,003
+1,497
| +2% | +$83.1K | 0.08% | 271 |
|
|
2023
Q1 | $5.59M | Sell |
96,506
-3,823
| -4% | -$258K | 0.09% | 254 |
|
|
2022
Q4 | $7.26M | Sell |
100,329
-9,290
| -8% | -$665K | 0.12% | 205 |
|
|
2022
Q3 | $6.66M | Buy |
109,619
+1,128
| +1% | +$72.1K | 0.12% | 219 |
|
|
2022
Q2 | $6.81M | Buy |
108,491
+1,548
| +1% | +$102K | 0.11% | 214 |
|
|
2022
Q1 | $7.52M | Buy |
106,943
+595
| +0.6% | +$40.2K | 0.11% | 227 |
|
|
2021
Q4 | $6.65M | Buy |
106,348
+3,498
| +3% | +$220K | 0.09% | 254 |
|
|
2021
Q3 | $6.35M | Buy |
102,850
+1,443
| +1% | +$86.9K | 0.09% | 263 |
|
|
2021
Q2 | $6.07M | Buy |
101,407
+2,376
| +2% | +$151K | 0.09% | 270 |
|
|
2021
Q1 | $6.02M | Buy |
99,031
+7,968
| +9% | +$440K | 0.09% | 251 |
|
|
2020
Q4 | $4.28M | Buy |
91,063
+5,114
| +6% | +$222K | 0.07% | 299 |
|
|
2020
Q3 | $3.19M | Sell |
85,949
-1,476
| -2% | -$56K | 0.06% | 326 |
|
|
2020
Q2 | $3.19M | Buy |
87,425
+2,363
| +3% | +$82.3K | 0.07% | 302 |
|
|
2020
Q1 | $2.6M | Sell |
85,062
-125,178
| -60% | -$5.55M | 0.06% | 297 |
|
|
2019
Q4 | $10.7M | Buy |
210,240
+3,097
| +1% | +$150K | 0.23% | 108 |
|
|
2019
Q3 | $9.77M | Buy |
207,143
+1,107
| +0.5% | +$52.8K | 0.22% | 111 |
|
|
2019
Q2 | $10.2M | Buy |
206,036
+6,132
| +3% | +$288K | 0.23% | 101 |
|
|
2019
Q1 | $8.51M | Sell |
199,904
-97,214
| -33% | -$4.3M | 0.19% | 132 |
|
|
2018
Q4 | $12.2M | Sell |
297,118
-393,043
| -57% | -$16.9M | 0.3% | 78 |
|
|
2018
Q3 | $32.2M | Sell |
690,161
-20,426
| -3% | -$933K | 0.71% | 17 |
|
|
2018
Q2 | $31M | Sell |
710,587
-57,798
| -8% | -$2.69M | 0.76% | 18 |
|
|
2018
Q1 | $35.3M | Buy |
768,385
+10,571
| +1% | +$513K | 0.88% | 13 |
|
|
2017
Q4 | $39.4M | Hold |
757,814
| – | – | 1.04% | 8 |
|
|
2017
Q3 | $39.4M | Buy |
757,814
+63,196
| +9% | +$3.08M | 1.02% | 8 |
|
|
2017
Q2 | $34M | Sell |
694,618
-7,379
| -1% | -$342K | 0.94% | 10 |
|
|
2017
Q1 | $33M | Buy |
+701,997
| New | +$33.5M | 0.94% | 10 |
|
Other funds holding MET
Oppenheimer Asset Management's MET Position: Q2 2026 in Review
Oppenheimer Asset Management reduced its MetLife (MET) stake by 85% in Q2 2026, selling an estimated $6.42M and leaving 14,228 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #701.
Oppenheimer Asset Management first reported a position in MET in Q1 2017 and has held it in 38 quarters since. The position peaked at $39.4M in Q4 2017. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Oppenheimer Asset Management held 14,228 shares of MetLife worth $1.2M as of Q2 2026.
- Oppenheimer Asset Management sold 79,543 MetLife shares in Q2 2026, an estimated $6.42M.
- MetLife made up 0.01% of Oppenheimer Asset Management's portfolio in Q2 2026, its #701 holding.
- Oppenheimer Asset Management first reported a position in MetLife in Q1 2017 and has held it in 38 quarters since.
- Oppenheimer Asset Management's MetLife position peaked at $39.4M in Q4 2017.
- 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.